Zealand Pharma A/S
ZLDPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $31,704,585 | $25,650,883 | $36,817,408 | $46,218,690 |
| - Cash | $936,521 | $7,244,047 | $776,151 | $480,303 |
| + Debt | $63,729 | $396,952 | $394,640 | $391,756 |
| Enterprise Value | $30,831,793 | $18,803,788 | $36,435,897 | $46,130,143 |
| Revenue | $49,569 | $9,088,284 | $8,092 | $9,056 |
| % Growth | -99.5% | 112,212% | -10.6% | – |
| Gross Profit | $6,640 | $9,087,874 | $7,687 | $8,648 |
| % Margin | 13.4% | 100% | 95% | 95.5% |
| EBITDA | -$352,512 | $8,124,571 | -$323,109 | -$277,065 |
| % Margin | -711.2% | 89.4% | -3,992.9% | -3,059.5% |
| Net Income | -$63,384 | $7,573,697 | -$335,343 | -$291,034 |
| % Margin | -127.9% | 83.3% | -4,144.1% | -3,213.7% |
| EPS Diluted | -0.9 | 105.61 | -4.75 | -4.64 |
| % Growth | -100.9% | 2,323.4% | -2.4% | – |
| Operating Cash Flow | -$69,584 | $8,519,317 | -$500,791 | -$180,477 |
| Capital Expenditures | -$571 | -$6,733 | -$8,758 | -$2,993 |
| Free Cash Flow | -$70,155 | $8,512,584 | -$509,549 | -$183,470 |